1. TAxI-peptide targeted Cas12a ribonuclease protein nanoformulations increase genome editing in hippocampal neurons
   Drew L. Sellers et al, 2023, Journal of Controlled Release CrossRef
2. Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
   Asmita Pal et al, 2020, Frontiers in Microbiology CrossRef
3. Vaccination and modern therapy of cervical cancer
   G. G. Khakimova, 2024, Medical alphabet CrossRef
4. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
   Farzaneh Zahedipour et al, 2024, Virus Research CrossRef
5. The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses
   Huafeng Lin et al, 2021, Frontiers in Cellular and Infection Microbiology CrossRef
6. CRISPR/Cas9 technology: A promising gene-editing tool for the treatment of cancers
   Muhammad Khairi Ahmad et al, 2023, Iranian Journal of Blood and Cancer CrossRef
7. Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells
   Zahra Noroozi et al, 2022, Scientific Reports CrossRef
8. Applications of CRISPR-Cas System in Tumor Biology
   Mengdan Ma et al, 2021, Oncologie CrossRef
9. CRISPR/Cas gene editing and delivery systems for cancer therapy
   Yingjie Li et al, 2024, WIREs Nanomedicine and Nanobiotechnology CrossRef
10. Research on CRISPR/system in major cancers and its potential in cancer treatments
    Z. Liu et al, 2021, Clinical and Translational Oncology CrossRef
11. ERA DA EDIÇÃO GÊNICA: APLICAÇÕES E FUTURO
    Bruna Petry et al, 2022, CIÊNCIAS AMBIENTAIS E DA SAÚDE NA ATUALIDADE: Insights para alcançar os Objetivos para o Desenvolvimento Sustentável CrossRef
12. Reprogrammed CRISPR‑Cas13a targeting the HPV16/18 E6 gene inhibits proliferation and induces apoptosis in E6‑transformed keratinocytes
    Chunjing Li et al, 2020, Experimental and Therapeutic Medicine CrossRef
13. Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
    Yuhao Wei et al, 2022, Frontiers in Immunology CrossRef